Similarly, high numbers of regulatory T cells (Tregs) in tumor tissue and blood are favorable prognostic factors in the HER2+/ER– subtype, whereas Tregs are correlated with poor outcome in ER+ breast cancer [34]. The gene discussed is ESR1; the disease is breast carcinoma.